Corteva (NYSE:CTVA) shares reached a new 52-week high after Jefferies raised its price target to $95 and reiterated a buy rating, contributing to a consensus “Moderate Buy” rating with an average target of $82.80. The company reported Q4 EPS in line with expectations but missed revenue, while setting FY2026 guidance and announcing a quarterly dividend. Insider activity showed a sale of 8,311 shares by Brian Titus, and institutional investors have adjusted their holdings.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Corteva (NYSE:CTVA) Reaches New 52-Week High After Analyst Upgrade
Corteva (NYSE:CTVA) shares reached a new 52-week high after Jefferies raised its price target to $95 and reiterated a buy rating, contributing to a consensus “Moderate Buy” rating with an average target of $82.80. The company reported Q4 EPS in line with expectations but missed revenue, while setting FY2026 guidance and announcing a quarterly dividend. Insider activity showed a sale of 8,311 shares by Brian Titus, and institutional investors have adjusted their holdings.